U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07701785) titled 'Superior Parietal iTBS for PD-MCI' on June 29.
Brief Summary: The goal of this study is to determine the whether a short-term, high-dose form of non-invasive brain stimulation (intermittent theta burst stimulation; iTBS) is a promising and safe treatment for mild cognitive impairment in Parkinson's disease (PD-MCI).
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease
Mild Cognitive Impairment
Intervention:
DEVICE: Accelerated intermittent theta-burst stimulation (iTBS) rTMS to right superior parietal lobule (rSPL)
Participants in this single-arm study will receive a accelerated course of intermit...